Anthrax Fusion Protein Therapy of Cancer

E-ISSN： 1875-5550|3|4|399-407

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.3, Iss.4, 2002-08, pp. : 399-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clearance mechanism of a mannosylated antibody–enzyme fusion protein used in experimental cancer therapy

By Kogelberg Heide Tolner Berend Sharma Surinder K. Lowdell Mark W Qureshi Uzma Robson Mathew Hillyer Tim Pedley R. Barbara Vervecken Wouter Contreras Roland Begent Richard H.J. Chester Kerry A.

Glycobiology, Vol. 17, Iss. 1, 2007-01 ,pp. : 36-45

Oxford University Press

Access to resources Recommend Favorite

Antibody–cytokine fusion proteins: applications in cancer therapy

By Ortiz-Sánchez Elizabeth Helguera Gustavo Daniels Tracy R Penichet Manuel L

Expert Opinion on Biological Therapy, Vol. 8, Iss. 5, 2008-05 ,pp. : 609-632

Informa Healthcare

Access to resources Recommend Favorite

DAB₃₈₉IL2 (ONTAK^®) fusion protein therapy of chronic lymphocytic leukaemia

By Frankel Arthur E Fleming Donald R Powell Bayard L Gartenhaus Ronald

Expert Opinion on Biological Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 179-186

Informa Healthcare

Access to resources Recommend Favorite

Is NSF a fusion protein?

By Morgan A. Burgoyne R.D.

Trends in Cell Biology, Vol. 5, Iss. 9, 1995-09 ,pp. : 335-339

Elsevier

Access to resources Recommend Favorite

A c-fos/Estrogen Receptor Fusion Protein Promotes Cell Cycle Progression and Proliferation of Human Cancer Cell Lines

By Crowe D.L. Brown T.N. Kim R. Smith S.M. Lee M.K.

Molecular Cell Biology Research Communications, Vol. 3, Iss. 4, 2000-04 ,pp. : 243-248

Academic Press

Access to resources Recommend Favorite